Skip to main content

Market Overview

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

30.70 -0.25 (-0.81%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
0.74
155.135M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
0.4
94.976M



Q4 2020
After-Hours
EPS:
REV:
0.62
100.446M
0.52
146.19M
0.57
143.557M
9.62%
-1.8%
Q3 2020
After-Hours
EPS:
REV:
0.54
102.14M
0.3
130.66M
0.74
155.135M
146.67%
18.73%
Q2 2020
After-Hours
EPS:
REV:
0.61
104.695M
0.45
127.86M
0.65
126.729M
44.44%
-0.88%
Q1 2020
After-Hours
EPS:
REV:
0.34
85.474M
0.28
83.48M
0.4
94.976M
42.86%
13.77%
Q4 2019
After-Hours
EPS:
REV:
0.48
115.934M
0.6
111.53M
0.62
100.446M
3.33%
-9.94%
Q3 2019
After-Hours
EPS:
REV:
0.52
102.996M
0.6
109.54M
0.54
102.14M
-10%
-6.76%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!